Single Dose PG102 in Patients With Active Psoriatic Arthritis

Mise à jour : Il y a 4 ans
Référence : NCT00787137

Femme et Homme

  • | Pays :
  • Serbia
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to evaluate the safety and tolerability of a single intravenous dose of PG102 in patients with psoriatic arthritis. The secondary objectives are to evaluate how PG102 moves around the body and to explore its effects on the disease.


Critère d'inclusion

  • Arthritis, Psoriatic

Liens